David S. Perlin

24.8k total citations · 6 hit papers
301 papers, 18.8k citations indexed

About

David S. Perlin is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, David S. Perlin has authored 301 papers receiving a total of 18.8k indexed citations (citations by other indexed papers that have themselves been cited), including 200 papers in Infectious Diseases, 159 papers in Epidemiology and 81 papers in Molecular Biology. Recurrent topics in David S. Perlin's work include Antifungal resistance and susceptibility (191 papers), Fungal Infections and Studies (131 papers) and ATP Synthase and ATPases Research (38 papers). David S. Perlin is often cited by papers focused on Antifungal resistance and susceptibility (191 papers), Fungal Infections and Studies (131 papers) and ATP Synthase and ATPases Research (38 papers). David S. Perlin collaborates with scholars based in United States, United Kingdom and Denmark. David S. Perlin's co-authors include Steven Park, Guillermo García‐Effrón, Maiken Cavling Arendrup, Ana Alastruey‐Izquierdo, Yanan Zhao, Riina Rautemaa‐Richardson, Susan J. Howard, Cristina Jiménez‐Ortigosa, James E. Haber and Milena Kordalewska and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

David S. Perlin

296 papers receiving 18.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The global problem of antifungal resistance: prevalence, mechanisms, and management

2017 757 citations David S. Perlin et al. profile →
Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

2013 620 citations Cristina Jiménez‐Ortigosa, David S. Perlin et al. Clinical Infectious Diseases profile →
Frequency and Evolution of Azole Resistance inAspergillus fumigatusAssociated with Treatment Failure1

2009 616 citations Alessandro C. Pasqualotto, David S. Perlin et al. profile →
Mechanisms of Antifungal Drug Resistance

2014 448 citations David S. Perlin et al. profile →
A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance

2017 421 citations Milena Kordalewska, David S. Perlin et al. profile →
A naturally inspired antibiotic to target multidrug-resistant pathogens

2022 158 citations Steven Park, David S. Perlin et al. profile →

Peers

Countries citing papers authored by David S. Perlin

Since Specialization

Citations

This map shows the geographic impact of David S. Perlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Perlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Perlin more than expected).

Fields of papers citing papers by David S. Perlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Perlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Perlin. The network helps show where David S. Perlin may publish in the future.

Co-authorship network of co-authors of David S. Perlin

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Perlin. A scholar is included among the top collaborators of David S. Perlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Perlin. David S. Perlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel Non-Hot Spot Modification in Fks1 of Candida auris Confers Echinocandin Resistance 2023 ·Antimicrobial Agents and Chemotherapy ·Milena Kordalewska, (unknown), João Nóbrega de Almeida, (unknown), (unknown), Arnaldo Lopes Colombo, David S. Perlin	19
2	ERG11 Analysis among Clinical Isolates of Trichosporon asahii with Different Azole Susceptibility Profiles 2022 ·Antimicrobial Agents and Chemotherapy ·João Nóbrega de Almeida, Cristina Jiménez‐Ortigosa, Elaine Cristina Francisco, Arnaldo Lopes Colombo, David S. Perlin	2
3	Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU 2022 ·Emerging Microbes & Infections ·Farnaz Daneshnia, João Nóbrega de Almeida, Amir Arastehfar, Lisa Lombardi, Erika Shor, (unknown), Ana Verena Almeida Mendes, Maria Goreth Barberino, Danilo Yamamoto Thomaz, Geraldine Butler, David S. Perlin, Arnaldo Lopes Colombo	33
4	Multifactorial Role of Mitochondria in Echinocandin Tolerance Revealed by Transcriptome Analysis of Drug-Tolerant Cells 2021 ·mBio ·Rocio Garcia‐Rubio, Cristina Jiménez‐Ortigosa, (unknown), (unknown), Erika Shor, David S. Perlin	20
5	Multidrug-resistantTrichosporonspecies: underestimated fungal pathogens posing imminent threats in clinical settings 2021 ·Critical Reviews in Microbiology ·Amir Arastehfar, João Nóbrega de Almeida, David S. Perlin, Macit İlkit, Teun Boekhout, Arnaldo Lopes Colombo	17
6	Adipose Tissue Regulates Pulmonary Pathology during TB Infection 2019 ·mBio ·(unknown), (unknown), (unknown), Christopher Vinnard, Selvakumar Subbian, David S. Perlin, Jyothi F. Nagajyothi	29
7	Membrane-Disrupting Nanofibrous Peptide Hydrogels 2019 ·ACS Biomaterials Science & Engineering ·Biplab Sarkar, Zain Siddiqui, Peter K. Nguyen, (unknown), Wanyi Fu, Steven Park, (unknown), (unknown), (unknown), Daiyong Deng, (unknown), Mengyan Li, David A. Sabatino, David S. Perlin, Wen Zhang, Jagannath Mondal, Vivek Kumar	36
8	<p>Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against <em>Candida albicans</em> and <em>Candida dubliniensis</em></p> 2019 ·Infection and Drug Resistance ·(unknown), Zoltán Tóth, David S. Perlin, Rudolf Gesztelyi, Gábor Kardos, Renátó Kovács, Fruzsina Nagy, Lajos Forgács, László Majoros	5
9	Novel FKS1 and FKS2 modifications in a high-level echinocandin resistant clinical isolate of Candida glabrata 2019 ·Emerging Microbes & Infections ·Xin Hou, Kelley R. Healey, Erika Shor, Milena Kordalewska, (unknown), Padmaja Paderu, Meng Xiao, He Wang, Ying Zhao, Li-Yan Lin, Yanhai Zhang, Yongzhe Li, Yingchun Xu, David S. Perlin, Yanan Zhao	40
10	Structure-Based Design of MptpB Inhibitors That Reduce Multidrug-Resistant Mycobacterium tuberculosis Survival and Infection Burden in Vivo 2018 ·Journal of Medicinal Chemistry ·Clare Vickers, (unknown), Ajanta Chakraborty, (unknown), Natalia Kurepina, Charis R. Saville, (unknown), Miquel Pons, (unknown), Maximiliano G. Gutiérrez, Steven Park, (unknown), David S. Perlin, Eric J. Thomas, Jim Cavet, Lydia Tabernero	39
11	Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata 2018 ·Journal of Fungi ·Kelley R. Healey, David S. Perlin	115
12	Clostridium difficile infection in Brazil: A neglected problem? 2014 ·American Journal of Infection Control ·(unknown), (unknown), Lílian Carla Carneiro, Ludmila Fiorenzano Baethgen, Rejane Giacomelli Tavares, (unknown), Steven Park, David S. Perlin, Édison Moraes Rodrigues Filho, Alessandro C. Pasqualotto	12
13	Are We Ready for Novel Detection Methods to Treat Respiratory Pathogens in Hospital-Acquired Pneumonia? 2011 ·Clinical Infectious Diseases ·Andrea Endimiani, Kristine M. Hujer, Andrea M. Hujer, Sebastian G. Kurz, Michael R. Jacobs, David S. Perlin, Robert A. Bonomo	57
14	High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease 2011 ·Clinical Infectious Diseases ·David W. Denning, Steven Park, Cornelia Lass‐Flörl, Marcin G. Fraczek, Marie Kirwan, Robin Gore, John A. Smith, Ahmed S. Bueid, Caroline B. Moore, Paul Bowyer, David S. Perlin	241
15	Rapid Real-Time Nucleic Acid Sequence-Based Amplification-Molecular Beacon Platform To Detect Fungal and Bacterial Bloodstream Infections 2009 ·Journal of Clinical Microbiology ·Yanan Zhao, Steven Park, Barry N. Kreiswirth, Christine C. Ginocchio, (unknown), Ali Laayoun, Alain Troesch, David S. Perlin	65
16	A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis , Candida orthopsilosis , and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility 2008 ·Antimicrobial Agents and Chemotherapy ·Guillermo García‐Effrón, Säntosh K. Katiyar, Steven Park, Thomas D. Edlind, David S. Perlin	255
17	Clinical performance of FXG: RESP (Asp+) assay for Pneumocystis jirovecii on respiratory specimens 2008 ·Lirias (KU Leuven) ·Philippe M. Hauser, Katrien Lagrou, (unknown), Cornelia Lass‐Flörl, David S. Perlin, (unknown), Johan Maertens, Michael Hughes, Paul Bowyer, David W. Denning, (unknown)	1
18	An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge 2006 ·Vaccine ·Amy Palin, Anasuya Chattopadhyay, Steven Park, Gilles Delmas, (unknown), Svetlana Senina, David S. Perlin, John K. Rose	30
19	Cross-Resistance of Clinical Isolates of Candida albicans and Candida glabrata to Over-the-Counter Azoles Used in the Treatment of Vaginitis 2000 ·Microbial Drug Resistance ·(unknown), Steven Park, David S. Perlin	47
20	Ion pumps as targets for therapeutic intervention: Old and new paradigms 1998 ·Electronic Journal of Biotechnology ·David S. Perlin	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact